Analytical Data
-
Gene name
FAM109B
- Application
-
Alternative Names
27KDA inositol polyphosphate phosphatase interacting protein B ;IPIP27B
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6ICB4
-
Expression Region
1-259aa
-
Molecular Weight
44.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM109B, a member of the FAM109 gene family, has garnered attention in recent years for its potential roles in cellular processes and disease mechanisms. Research indicates that FAM109B is involved in regulating cellular proliferation and apoptosis, and aberrations in its expression may be linked to various cancers. Its precise biological function, however, remains largely unexplored. The production of recombinant FAM109B protein is a crucial step in elucidating its molecular characteristics and functional properties. By generating and characterizing this protein, researchers aim to investigate its interactions with cellular pathways, assess its impact on cancer cell behavior, and identify potential therapeutic targets. Additionally, studying the recombinant protein allows for the development of antibodies that can facilitate further studies on the protein's expression patterns and functional roles in normal and pathological states. Understanding FAM109B's biological significance could provide insights into its potential as a biomarker for cancer diagnosis and as a target for innovative treatment strategies, highlighting its importance in the field of molecular biology and oncology.
